NASDAQ:ARDM - Aradigm Stock Price, Price Target & More

$1.54 -0.03 (-1.91 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$1.57
Today's Range$1.52 - $1.58
52-Week Range$0.78 - $7.35
Volume39,554 shs
Average Volume328,533 shs
Market Capitalization$25.94 million
P/E Ratio-2.14
Dividend YieldN/A
Beta0.89

About Aradigm (NASDAQ:ARDM)

Aradigm logoAradigm Corporation, a specialty pharmaceutical company, focuses on the development and commercialization of drugs for the prevention and treatment of severe respiratory diseases. The company's lead development candidates are proprietary formulations of the potent antibiotic ciprofloxacin, including Linhaliq (ARD-3150) and Lipoquin (ARD-3100) that are delivered by inhalation for the management of infections associated with severe respiratory diseases, including non-cystic fibrosis bronchiectasis and cystic fibrosis. It is also developing inhaled ciprofloxacin formulations for treatment of patients with cystic fibrosis and non-tuberculous mycobacteria, as well as the prevention and treatment of high threat and bioterrorism infections, such as inhaled tularemia, pneumonic plague, melioidosis, Q fever, and inhaled anthrax. The company has collaboration agreements with Oregon State University and Grifols, S.A. Aradigm Corporation was founded in 1991 and is headquartered in Hayward, California.

Receive ARDM News and Ratings via Email

Sign-up to receive the latest news and ratings for ARDM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:ARDM
CUSIPN/A
Phone510-265-9000

Debt

Debt-to-Equity Ratio-1.20%
Current Ratio1.41%
Quick Ratio1.41%

Price-To-Earnings

Trailing P/E Ratio-2.14
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$14.47 million
Price / Sales1.61
Cash FlowN/A
Price / CashN/A
Book Value($0.83) per share
Price / Book-1.86

Profitability

EPS (Most Recent Fiscal Year)($0.72)
Net Income$-10,700,000.00
Net Margins-74.01%
Return on EquityN/A
Return on Assets-77.68%

Miscellaneous

Employees23
Outstanding Shares15,170,000

How to Become a New Pot Stock Millionaire

Aradigm (NASDAQ:ARDM) Frequently Asked Questions

What is Aradigm's stock symbol?

Aradigm trades on the NASDAQ under the ticker symbol "ARDM."

How were Aradigm's earnings last quarter?

Aradigm (NASDAQ:ARDM) posted its quarterly earnings results on Thursday, March, 29th. The company reported ($0.28) EPS for the quarter, beating the consensus estimate of ($0.36) by $0.08. The business earned $2.37 million during the quarter. View Aradigm's Earnings History.

When is Aradigm's next earnings date?

Aradigm is scheduled to release their next quarterly earnings announcement on Monday, May, 21st 2018. View Earnings Estimates for Aradigm.

What price target have analysts set for ARDM?

1 Wall Street analysts have issued 12 month price objectives for Aradigm's stock. Their forecasts range from $10.00 to $10.00. On average, they anticipate Aradigm's share price to reach $10.00 in the next twelve months. View Analyst Ratings for Aradigm.

Who are some of Aradigm's key competitors?

Who are Aradigm's key executives?

Aradigm's management team includes the folowing people:
  • Dr. John M. Siebert, Exec. Chairman, Interim Principal Exec. Officer & Acting Principal Financial Officer (Age 78)
  • Dr. David Cipolla Ph.D., VP of Preclinical R&D
  • Ms. Janice Dahms, VP of Project Management

Has Aradigm been receiving favorable news coverage?

Media coverage about ARDM stock has trended somewhat positive on Saturday, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Aradigm earned a media sentiment score of 0.16 on Accern's scale. They also assigned media coverage about the company an impact score of 47.44 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

Who are Aradigm's major shareholders?

Aradigm's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include FIRST EAGLE INVESTMENT MANAGEMENT, LLC (26.31%) and FIRST EAGLE INVESTMENT MANAGEMENT, LLC (26.31%). View Institutional Ownership Trends for Aradigm.

How do I buy shares of Aradigm?

Shares of ARDM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aradigm's stock price today?

One share of ARDM stock can currently be purchased for approximately $1.54.

How big of a company is Aradigm?

Aradigm has a market capitalization of $25.94 million and generates $14.47 million in revenue each year. The company earns $-10,700,000.00 in net income (profit) each year or ($0.72) on an earnings per share basis. Aradigm employs 23 workers across the globe.

How can I contact Aradigm?

Aradigm's mailing address is 3929 POINT EDEN WAY, HAYWARD CA, 94545. The company can be reached via phone at 510-265-9000 or via email at [email protected]


MarketBeat Community Rating for Aradigm (ARDM)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  92 (Vote Outperform)
Underperform Votes:  180 (Vote Underperform)
Total Votes:  272
MarketBeat's community ratings are surveys of what our community members think about Aradigm and other stocks. Vote "Outperform" if you believe ARDM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARDM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Aradigm (NASDAQ:ARDM) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Aradigm in the last 12 months. Their average twelve-month price target is $10.00, suggesting that the stock has a possible upside of 549.35%. The high price target for ARDM is $10.00 and the low price target for ARDM is $10.00. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.002.002.003.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $10.00$10.00$10.00$10.00
Price Target Upside: 549.35% upside160.42% upside160.42% upside295.26% upside

Aradigm (NASDAQ:ARDM) Consensus Price Target History

Price Target History for Aradigm (NASDAQ:ARDM)

Aradigm (NASDAQ:ARDM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/12/2018Ladenburg ThalmannDowngradeBuy -> NeutralHighView Rating Details
(Data available from 4/21/2016 forward)

Earnings

Aradigm (NASDAQ:ARDM) Earnings History and Estimates Chart

Earnings by Quarter for Aradigm (NASDAQ:ARDM)

Aradigm (NASDAQ:ARDM) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.07 EPS

Aradigm (NASDAQ ARDM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/21/2018        
3/29/2018Q4 2017($0.36)($0.28)$2.37 millionViewN/AView Earnings Details
11/2/2017Q3 2017($0.31)($0.26)$2.73 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.30)$0.07$7.68 millionViewN/AView Earnings Details
5/15/2017Q1 2017($0.43)($0.2490)$1.69 millionViewN/AView Earnings Details
3/28/2017Q4 2016($0.37)($0.54)$0.13 millionViewN/AView Earnings Details
11/9/2016Q3 2016($0.53)($0.55)$0.05 millionViewN/AView Earnings Details
8/10/2016Q2($0.59)($0.59)$0.01 millionViewN/AView Earnings Details
5/10/2016Q1($0.59)($0.55)$0.01 millionViewN/AView Earnings Details
3/15/2016Q415($0.55)($0.63)$0.04 millionViewN/AView Earnings Details
11/11/2015Q3($0.19)($0.38)$4.67 millionViewN/AView Earnings Details
8/13/2015Q2($0.08)($0.08)$11.60 million$10.00 millionViewN/AView Earnings Details
5/11/2015Q1($0.06)($0.08)$8.77 millionViewN/AView Earnings Details
3/17/2015Q414($0.07)($0.06)$6.70 million$8.10 millionViewN/AView Earnings Details
11/7/2014Q314($0.10)($0.06)$4.80 million$6.60 millionViewN/AView Earnings Details
8/7/2014Q214($0.09)($0.09)$4.25 million$12.20 millionViewN/AView Earnings Details
5/14/2014Q1 2014$0.40$6.63 millionViewN/AView Earnings Details
10/28/2013Q3 13($0.04)$4.55 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.40)$0.25 millionViewN/AView Earnings Details
5/14/2013Q1 2013($0.40)$0.28 millionViewN/AView Earnings Details
3/26/2013Q4 2012($0.40)ViewN/AView Earnings Details
11/8/2012Q3 2012($0.40)($0.40)ViewN/AView Earnings Details
8/9/2012Q2 2012($0.40)($0.36)ViewN/AView Earnings Details
5/11/2012Q1 2012($0.40)($0.40)ViewN/AView Earnings Details
3/27/2012Q4 2011($0.40)($0.32)ViewN/AView Earnings Details
11/10/2011Q3 2011($0.80)($0.52)ViewN/AView Earnings Details
8/9/2011Q2 2011($0.80)($0.68)ViewN/AView Earnings Details
5/12/2011Q1 2011($0.80)($0.56)ViewN/AView Earnings Details
3/24/2011Q4 2010($0.56)ViewN/AView Earnings Details
11/11/2010Q3 2010($1.20)($0.88)ViewN/AView Earnings Details
8/12/2010Q2 2010($2.00)($1.56)ViewN/AView Earnings Details
5/13/2010Q1 2010($0.08)ViewN/AView Earnings Details
3/23/2010Q4 2009($0.80)($1.36)ViewN/AView Earnings Details
11/5/2009Q3 2009($1.20)$0.40ViewN/AView Earnings Details
8/6/2009Q2 2009($2.00)($1.76)ViewN/AView Earnings Details
5/12/2009Q1 2009($3.60)($2.96)ViewN/AView Earnings Details
3/25/2009Q4 2008($5.20)($3.92)ViewN/AView Earnings Details
11/12/2008Q3 2008($5.20)($3.36)ViewN/AView Earnings Details
8/8/2008Q2 2008($4.80)($5.20)ViewN/AView Earnings Details
3/25/2008Q4 2007($4.00)($5.36)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Aradigm (NASDAQ:ARDM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Aradigm (NASDAQ ARDM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 7.30%
Institutional Ownership Percentage: 36.88%
Insider Trading History for Aradigm (NASDAQ:ARDM)
Insider Trading History for Aradigm (NASDAQ:ARDM)

Aradigm (NASDAQ ARDM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2018Juergen Kurt FroehlichInsiderSell17,011$1.53$26,026.8390,853View SEC Filing  
4/4/2017Juergen Kurt FroehlichInsiderSell3,765$1.51$5,685.1585,129View SEC Filing  
10/4/2016Juergen Kurt FroehlichInsiderSell423$6.76$2,859.4888,894View SEC Filing  
6/21/2016Juergen Kurt FroehlichInsiderSell333$4.45$1,481.85View SEC Filing  
12/13/2013Virgil ThompsonDirectorSell3,340$0.17$567.80View SEC Filing  
8/27/2013First Eagle Investment ManagemMajor ShareholderBuy40,322,580$0.12$4,838,709.60View SEC Filing  
12/11/2012First Eagle Investment ManagemMajor ShareholderBuy41,666,667$0.12$5,000,000.04View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Aradigm (NASDAQ ARDM) News Headlines

Source:
DateHeadline
Juniper Pharmaceuticals: Undervalued With Double-Digit Revenue GrowthJuniper Pharmaceuticals: Undervalued With Double-Digit Revenue Growth
seekingalpha.com - April 19 at 5:40 PM
CHEK On Watch, ARQL Inks A Deal, RTTR To Move RP-G28 Into Phase IIICHEK On Watch, ARQL Inks A Deal, RTTR To Move RP-G28 Into Phase III
www.finanznachrichten.de - April 18 at 8:16 AM
Aradigm (ARDM) versus Helius Medical Technologies (HSDT) Financial ReviewAradigm (ARDM) versus Helius Medical Technologies (HSDT) Financial Review
www.americanbankingnews.com - April 15 at 5:18 PM
Aradigm (ARDM) Lowered to Sell at Zacks Investment ResearchAradigm (ARDM) Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - April 13 at 5:29 PM
Aradigm (ARDM) Upgraded to "Buy" at Zacks Investment ResearchAradigm (ARDM) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - April 9 at 11:59 PM
Wired News – EMA Completed Validation of MAA for Aradigm’s Linhaliq in Non-Cystic Fibrosis BronchiectasisWired News – EMA Completed Validation of MAA for Aradigm’s Linhaliq in Non-Cystic Fibrosis Bronchiectasis
finance.yahoo.com - April 9 at 8:18 AM
BRIEF-Aradigm Announces EMA Has Completed Its Validation Of The MAA SubmissionBRIEF-Aradigm Announces EMA Has Completed Its Validation Of The MAA Submission
www.reuters.com - April 6 at 5:42 PM
Aradigm Corp. (ARDM) Announces EMA Has Completed Its Validation of MAA SubmissionAradigm Corp. (ARDM) Announces EMA Has Completed Its Validation of MAA Submission
www.streetinsider.com - April 5 at 5:18 PM
EMA accepts Aradigms marketing application for Linhaliq for certain lung infections; shares ahead 9%EMA accepts Aradigm's marketing application for Linhaliq for certain lung infections; shares ahead 9%
seekingalpha.com - April 5 at 10:31 AM
 Aradigm (ARDM) Receives Average Rating of "Hold" from Brokerages Aradigm (ARDM) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - April 1 at 1:26 AM
Aradigm net loss improves in Q4Aradigm net loss improves in Q4
seekingalpha.com - March 24 at 5:15 PM
Aradigm (ARDM) Posts  Earnings Results, Misses Estimates By $0.03 EPSAradigm (ARDM) Posts Earnings Results, Misses Estimates By $0.03 EPS
www.americanbankingnews.com - March 24 at 1:24 PM
BRIEF-Aradigm Reports Q4 Loss Per Share Of $0.28BRIEF-Aradigm Reports Q4 Loss Per Share Of $0.28
www.reuters.com - March 23 at 5:42 PM
Zacks Investment Research Upgrades Aradigm (ARDM) to HoldZacks Investment Research Upgrades Aradigm (ARDM) to Hold
www.americanbankingnews.com - March 19 at 5:34 PM
Aradigm (ARDM) to Release Quarterly Earnings on MondayAradigm (ARDM) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - March 19 at 1:12 AM
Glancy Prongay & Murray LLP Reminds Investors of the March 12, 2018 Deadline in the Class Action Lawsuit Against Aradigm CorporationGlancy Prongay & Murray LLP Reminds Investors of the March 12, 2018 Deadline in the Class Action Lawsuit Against Aradigm Corporation
finance.yahoo.com - March 12 at 6:40 PM
FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018
finance.yahoo.com - March 12 at 6:40 PM
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation And Reminds Investors With Losses To Contact The FirmDEADLINE TODAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation And Reminds Investors With Losses To Contact The Firm
finance.yahoo.com - March 12 at 6:40 PM
DEADLINE REMINDER NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation And Reminds Investors With Losses To Contact The FirmDEADLINE REMINDER NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation And Reminds Investors With Losses To Contact The Firm
finance.yahoo.com - March 10 at 6:24 PM
March 12th Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aradigm Corporation (ARDM)March 12th Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aradigm Corporation (ARDM)
finance.yahoo.com - March 10 at 6:24 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Aradigm Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2018 - ARDMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Aradigm Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2018 - ARDM
finance.yahoo.com - March 10 at 6:24 PM
MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation And Reminds Investors With Losses To Contact The FirmMONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation And Reminds Investors With Losses To Contact The Firm
finance.yahoo.com - March 10 at 6:24 PM
MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm CorporationMONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation
finance.yahoo.com - March 8 at 6:45 PM
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Aradigm Corporation Investors (ARDM)Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Aradigm Corporation Investors (ARDM)
finance.yahoo.com - March 8 at 6:45 PM
ARDM EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Aradigm Corporation and a Lead Plaintiff Deadline of March 12, 2018ARDM EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Aradigm Corporation and a Lead Plaintiff Deadline of March 12, 2018
finance.yahoo.com - March 8 at 6:45 PM
5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation
finance.yahoo.com - March 7 at 6:35 PM
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018
finance.yahoo.com - March 7 at 6:35 PM
IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm CorporationIMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation
finance.yahoo.com - March 6 at 8:15 AM
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Aradigm Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2018 – ARDMEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Aradigm Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2018 – ARDM
finance.yahoo.com - March 5 at 5:50 PM
FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders of Approaching Deadline in Class Action Lawsuit and Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Aradigm Corporation to Contact the FirmFINAL DEADLINE ALERT: Brower Piven Reminds Shareholders of Approaching Deadline in Class Action Lawsuit and Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Aradigm Corporation to Contact the Firm
finance.yahoo.com - March 3 at 8:16 AM
The Klein Law Firm Reminds Shareholders of Aradigm Corporation of Commencement of a Class Action and a Lead Plaintiff Deadline of March 12, 2018 (ARDM)The Klein Law Firm Reminds Shareholders of Aradigm Corporation of Commencement of a Class Action and a Lead Plaintiff Deadline of March 12, 2018 (ARDM)
finance.yahoo.com - March 2 at 6:11 PM
DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm CorporationDEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation
finance.yahoo.com - March 2 at 6:11 PM
Aradigm: Points Of DiscussionAradigm: Points Of Discussion
seekingalpha.com - March 1 at 5:52 PM
MARCH 12 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm CorporationMARCH 12 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation
finance.yahoo.com - March 1 at 5:52 PM
ARDM SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Aradigm Corporation and a Lead Plaintiff Deadline of March 12, 2018ARDM SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Aradigm Corporation and a Lead Plaintiff Deadline of March 12, 2018
finance.yahoo.com - March 1 at 5:52 PM
ARADIGM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Aradigm Corporation To Contact The FirmARADIGM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Aradigm Corporation To Contact The Firm
finance.yahoo.com - February 28 at 8:17 AM
The Klein Law Firm Reminds Investors in Aradigm Corporation of a Class Action and a Lead Plaintiff Deadline of March 12, 2018 (ARDM)The Klein Law Firm Reminds Investors in Aradigm Corporation of a Class Action and a Lead Plaintiff Deadline of March 12, 2018 (ARDM)
finance.yahoo.com - February 26 at 5:45 PM
Glancy Prongay & Murray LLP Continues Investigation on Behalf of Aradigm Corporation Investors (ARDM)Glancy Prongay & Murray LLP Continues Investigation on Behalf of Aradigm Corporation Investors (ARDM)
finance.yahoo.com - February 26 at 5:45 PM
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Aradigm Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2018 - ARDMINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Aradigm Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2018 - ARDM
finance.yahoo.com - February 23 at 5:59 PM
Pawar Law Group Reminds Aradigm Corporation Investors of Important March 12, 2018 Lead Plaintiff Deadline in Class Action - ARDMPawar Law Group Reminds Aradigm Corporation Investors of Important March 12, 2018 Lead Plaintiff Deadline in Class Action - ARDM
finance.yahoo.com - February 21 at 5:27 PM
INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018
finance.yahoo.com - February 21 at 8:21 AM
Can Aradigm Corporation (NASDAQ:ARDM) Improve Your Portfolio Returns?Can Aradigm Corporation (NASDAQ:ARDM) Improve Your Portfolio Returns?
finance.yahoo.com - February 20 at 5:47 PM
ARDM NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Aradigm Corporation -- ARDMARDM NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Aradigm Corporation -- ARDM
finance.yahoo.com - February 19 at 5:10 PM
The Klein Law Firm Reminds Shareholders of Aradigm Corporation of a Class Action and a Lead Plaintiff Deadline of March 12, 2018 (ARDM)The Klein Law Firm Reminds Shareholders of Aradigm Corporation of a Class Action and a Lead Plaintiff Deadline of March 12, 2018 (ARDM)
finance.yahoo.com - February 15 at 5:21 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aradigm Corporation of Class Action Lawsuit and Upcoming Deadline – ARDMSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aradigm Corporation of Class Action Lawsuit and Upcoming Deadline – ARDM
finance.yahoo.com - February 15 at 9:30 AM
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Aradigm Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2018 - ARDMEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Aradigm Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2018 - ARDM
finance.yahoo.com - February 14 at 4:04 PM
FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm CorporationFINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation
finance.yahoo.com - February 14 at 4:04 PM
ARDM INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Aradigm Corporation InvestorsARDM INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Aradigm Corporation Investors
finance.yahoo.com - February 14 at 9:43 AM
INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018
finance.yahoo.com - February 13 at 3:43 PM
DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm CorporationDEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation
finance.yahoo.com - February 13 at 3:43 PM

SEC Filings

Aradigm (NASDAQ:ARDM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Aradigm (NASDAQ:ARDM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Aradigm (NASDAQ ARDM) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.